➢ Product Name — Keoni CBD Gummies
When a product is in violation of the FD&C Act, FDA considers many factors in deciding whether or not to initiate an enforcement action.
Those factors include, among other things, agency resources and the threat to the public health. FDA also may consult with its federal and state partners in making decisions about whether to initiate a federal enforcement action. A. The FDA has sent warning letters in the past to companies illegally selling CBD products that claimed to prevent, diagnose, treat, or cure serious diseases, such as cancer.
➢ Go And Visit — https://www.supplementz.org/keoni-cbd-gummies/
➢ Read Some Relatable Articles